1. Abbott Laboratories Corporation (10 from 4,177 patents)

2. Rempex Pharmaceuticals, Inc. (8 from 27 patents)

3. Janssen Pharmaceutica Nv (3 from 2,076 patents)

4. Abbott Gmbh & Co Kg (3 from 139 patents)

5. Melinta Subsidiary Corp. (3 from 13 patents)

6. Sgx Pharmaceuticals, Inc. (2 from 17 patents)

7. Abbvie Inc. (1 from 822 patents)

8. Endosome Therapeutics, Inc. (1 from 1 patent)

9. Abbott Gmbh & Cco. Kg (1 from 1 patent)

10. Melinta Therapeutics, Inc. (23 patents)

11. Abbvie Bahamas Limited (6 patents)

1. 12171772 - Therapeutic uses of pharmaceutical compositions comprising cyclic boronic acid ester derivatives

2. 11897900 - Inhibitors of KEAP1-Nrf2 protein-protein interaction

3. 11684629 - Therapeutic uses of pharmaceutical compositions comprising cyclic boronic acid ester derivatives

4. 11427601 - Inhibitors of KEAP1-Nrf2 protein-protein interaction

5. 11324832 - Tripartite modulators of endosomal G protein-coupled receptors

6. 11090319 - Therapeutic uses of pharmaceutical compositions comprising cyclic boronic acid ester derivatives

7. 10947252 - Inhibitors of KEAP1-Nrf2 protein-protein interaction

8. 10639318 - Therapeutic uses of pharmaceutical compositions comprising cyclic boronic acid ester derivatives

9. 10183034 - Therapeutic uses of pharmaceutical compositions comprising cyclic boronic acid ester derivatives

10. 10172874 - Pharmaceutical compositions comprising cyclic boronic acid ester derivatives

11. 10004758 - Cyclic boronic acid ester derivatives and methods of making the same

12. 9694025 - Cyclic boronic acid ester derivatives and therapeutic uses thereof

13. 9296763 - Cyclic boronic acid ester derivatives and therapeutic uses thereof

14. 8680136 - Cyclic boronic acid ester derivatives and therapeutic uses thereof

15. 8546374 - Amino-tetrazoles analogues and methods of use